Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07275125

Outcomes of Drug Resistant Epileptic Pediatric Patient by Modified Atkins Diet

To assess clinical outcomes in drug resistant epileptic pediatric patient by modified atkin diet with focusing on following points:

1. Control of seizures(frequency , duration and numbers of hospital admissions) . 2. Quality of life by pediatric quality of life inventory v4. 3. Cognitive function by stanford binet intelligence scale 5th edition. 4. Growth parameters ( weight, height will be combined to report BMI in kg/m^2).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Drug Resistant Epilepsy Brain Diseases Central Nervous System Diseases Epilepsy Nervous System Diseases

Age range

1 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children aged 1-18 years.
  • Diagnosed with drug-resistant epilepsy according to ILAE definition.[2]
  • On KD for at least 6 months.

Exclusion criteria

  • - Patients with contraindicated metabolic/genetic conditions.
  • Non-compliance with KD .

Patients on alternative dietary therapies (e.g., low glycemic diet)

Treatment and study plan

Primary outcomes

  1. 1-Control of seizures(frequency and duration of seizures) . 2-Quality of life by pediatric quality of life inventory v4. 3-Cognitive function by stanford binet intelligence scale 5th edition. 4-Growth parameters (weight and height by BMI in kg/m^2)

    Time frame: 6 month

Secondary outcomes

  1. to detect clinical predictors of seizures control ( frequency of attack and duration) in patients with drug resistant epilepsy using MAD.

    Time frame: 6 month

Study contacts

Contact information is provided by the study sponsor or research team.

Mahmoud Saber Elsayed

CONTACT

[email protected]

00201069770585

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 10, 2025
Registry last updated
Dec 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.